TABLE 1. Percentage of nonserious and serious adverse events after receipt of Janssen COVID-19 vaccine, by demographic characteristics of vaccine recipients and reported symptoms — Vaccine Adverse Event Reporting System, United States, March–April 2021.
| Characteristic | Total (N = 13,725) | Severity
of adverse event, %* |
||
|---|---|---|---|---|
| Nonserious (n = 13,294) | Serious, excluding death (n = 343) | Death (n = 88) | ||
|
Sex
| ||||
| Female |
66.2
|
66.6 |
57.1 |
50.0 |
| Male |
31.2
|
30.8 |
40.5 |
43.2 |
| Unknown |
2.6
|
2.6 |
2.3 |
6.8 |
|
Age group,
yrs
| ||||
| 0–17 |
1.5
|
1.6 |
0.6 |
0.0 |
| 18–49 |
57.0
|
57.9 |
34.4 |
13.6 |
| 50–64 |
26.8
|
26.7 |
33.8 |
18.2 |
| 65–74 |
6.8
|
6.5 |
14.3 |
18.2 |
| 75–84 |
1.8
|
1.5 |
6.4 |
15.9 |
| ≥85 |
0.6
|
0.4 |
3.2 |
19.3 |
| Unknown |
5.6
|
5.5 |
7.3 |
14.8 |
|
Race/Ethnicity
| ||||
| Hispanic or Latino |
7.3
|
7.3 |
6.1 |
1.1 |
| Non-Hispanic or
Latino | ||||
| American Indian or Alaska Native |
0.2
|
0.2 |
0.0 |
0.0 |
| Asian |
2.3
|
2.3 |
1.5 |
3.4 |
| Black |
3.4
|
3.3 |
5.5 |
8.0 |
| Native
Hawaiian or Pacific Islander |
0.1
|
0.1 |
0.0 |
0.0 |
| White |
58.4
|
58.6 |
52.2 |
45.5 |
| Multiracial |
1.3
|
1.3 |
0.9 |
0.0 |
| Other |
0.4
|
0.4 |
0.3 |
1.1 |
| Unknown race |
0.5
|
0.5 |
1.5 |
2.3 |
| Unknown
ethnicity | ||||
| American Indian or Alaska Native |
0.1
|
0.1 |
0.0 |
0.0 |
| Asian |
0.3
|
0.3 |
0.6 |
2.3 |
| Black |
0.8
|
0.7 |
2.6 |
1.1 |
| Native
Hawaiian or Pacific Islander |
<0.1
|
<0.1 |
0.0 |
0.0 |
| White |
5.8
|
5.7 |
8.8 |
9.1 |
| Multiracial |
0.2
|
0.2 |
0.0 |
0.0 |
| Other |
1.7
|
1.7 |
0.9 |
0.0 |
| Unknown
race/ethnicity |
17.4
|
17.3 |
19.2 |
26.1 |
|
Reported
symptoms
| ||||
| Headache |
34.4
|
35.0 |
17.8 |
6.8 |
| Fever |
33.7
|
34.2 |
21.6 |
8.0 |
| Chills |
32.7
|
33.3 |
14.9 |
4.6 |
| Pain |
25.5
|
26.1 |
10.2 |
1.1 |
| Fatigue | 23.9 | 24.3 | 12.8 | 5.7 |
* Reports are classified as serious if any of the following are reported: death, life-threatening illness, hospitalization or prolongation of hospitalization, permanent disability, congenital anomaly, or birth defect.